| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 2.38e-13 | 37 | 160 | 10 | GO:0004190 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 3.20e-13 | 38 | 160 | 10 | GO:0070001 |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 CNOT1 PRAMEF6 | 5.04e-10 | 55 | 160 | 9 | GO:0042974 |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | PRAMEF7 PRAMEF5 KBTBD2 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 RPTOR PRAMEF14 PRAMEF6 | 4.63e-09 | 95 | 160 | 10 | GO:0140767 |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 NLRP1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 F2 USP6 CAPN7 ERVK-8 ERVK-18 USP7 PAPPA ERVK-19 PRSS45P ERVK-25 ERVK-24 CTSO | 1.15e-08 | 430 | 160 | 18 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.38e-08 | 11 | 160 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | PRAMEF7 PRAMEF5 KBTBD2 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 1.93e-08 | 82 | 160 | 9 | GO:1990756 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 5.86e-08 | 14 | 160 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.44e-07 | 18 | 160 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 PM20D1 NLRP1 SCRN1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 F2 USP6 CAPN7 ERVK-8 ERVK-18 USP7 PAPPA ERVK-19 PRSS45P ERVK-25 ERVK-24 CTSO | 2.99e-07 | 654 | 160 | 20 | GO:0008233 |
| GeneOntologyMolecularFunction | nuclear receptor binding | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 TRIP12 STAT3 PRAMEF14 CNOT1 PRAMEF6 | 3.35e-07 | 187 | 160 | 11 | GO:0016922 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 5.69e-07 | 21 | 160 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.63e-06 | 28 | 160 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.10e-05 | 37 | 160 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.10e-05 | 37 | 160 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.26e-05 | 38 | 160 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.26e-05 | 46 | 160 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | 5-diphosphoinositol pentakisphosphate 1-kinase activity | 6.38e-05 | 2 | 160 | 2 | GO:0033857 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 1.14e-04 | 136 | 160 | 7 | GO:0004540 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 TRIP12 STAT3 STK4 PRAMEF14 CNOT1 PRAMEF6 | 1.40e-04 | 417 | 160 | 12 | GO:0061629 |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.47e-04 | 70 | 160 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | TRPM6 GABRG3 BEST3 HCN2 RYR1 RYR3 SLC9C1 CLCN1 NALCN OTOP1 GRIN3A KCNH5 | 3.38e-04 | 459 | 160 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 3-kinase activity | 3.79e-04 | 4 | 160 | 2 | GO:0052724 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 1-kinase activity | 3.79e-04 | 4 | 160 | 2 | GO:0052723 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 3.79e-04 | 4 | 160 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 4.34e-04 | 79 | 160 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | protein-arginine deiminase activity | 6.28e-04 | 5 | 160 | 2 | GO:0004668 | |
| GeneOntologyMolecularFunction | diphosphoinositol pentakisphosphate kinase activity | 6.28e-04 | 5 | 160 | 2 | GO:0000829 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate kinase activity | 6.28e-04 | 5 | 160 | 2 | GO:0000828 | |
| GeneOntologyMolecularFunction | inositol-1,3,4,5,6-pentakisphosphate kinase activity | 6.28e-04 | 5 | 160 | 2 | GO:0000827 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 5-kinase activity | 6.28e-04 | 5 | 160 | 2 | GO:0000832 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 ZGRF1 UBR4 ERVK-7 ERVK-21 ERVK-9 ERVK-10 TRIP12 RASGRP1 TRIM67 SEC24B ERVK-8 ERVK-5 PAPPA ERVK-19 ERVK-24 ERVK-11 | 8.19e-04 | 891 | 160 | 17 | GO:0008270 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 9.37e-04 | 6 | 160 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | channel activity | TRPM6 GABRG3 BEST3 HCN2 RYR1 RYR3 SLC9C1 CLCN1 NALCN OTOP1 GRIN3A KCNH5 | 1.10e-03 | 525 | 160 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | TRPM6 GABRG3 BEST3 HCN2 RYR1 RYR3 SLC9C1 CLCN1 NALCN OTOP1 GRIN3A KCNH5 | 1.12e-03 | 526 | 160 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.27e-03 | 262 | 160 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | pre-mRNA 3'-splice site binding | 1.31e-03 | 7 | 160 | 2 | GO:0030628 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.38e-03 | 151 | 160 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.31e-03 | 33 | 160 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | phosphatidylcholine binding | 2.52e-03 | 34 | 160 | 3 | GO:0031210 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 TRIP12 STAT3 STK4 PRAMEF14 CNOT1 PRAMEF6 | 2.59e-03 | 582 | 160 | 12 | GO:0140297 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.62e-03 | 118 | 160 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | nuclease activity | 2.65e-03 | 231 | 160 | 7 | GO:0004518 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ADCY10 ERVK-6 CYP7A1 ZGRF1 UBR4 ERVK-7 ERVK-21 ERVK-9 ERVK-10 TRIP12 RASGRP1 TRIM67 SEC24B ERVK-8 ERVK-5 PAPPA ERVK-19 ERVK-24 ERVK-11 | 3.16e-03 | 1189 | 160 | 19 | GO:0046914 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | TRPM6 GABRG3 BEST3 HCN2 RYR1 RYR3 SLC9C1 CLCN1 NALCN OTOP1 GRIN3A ATP2A1 ATP2A2 KCNH5 | 3.18e-03 | 758 | 160 | 14 | GO:0015318 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 3.35e-03 | 11 | 160 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | inositol phosphate kinase activity | 3.35e-03 | 11 | 160 | 2 | GO:0180030 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines | 3.35e-03 | 11 | 160 | 2 | GO:0016813 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNHD1 ABCA1 ZGRF1 NLRP1 DNAH1 DNAH12 MDN1 SHPRH ATP2A1 ATP2A2 DNAH6 DNAH9 | 3.99e-03 | 614 | 160 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TRPM6 HCN2 RYR1 RYR3 SLC9C1 NALCN GRIN3A ATP2A1 ATP2A2 KCNH5 | 4.35e-03 | 465 | 160 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 4.68e-03 | 193 | 160 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | poly(A)-specific ribonuclease activity | 4.70e-03 | 13 | 160 | 2 | GO:0004535 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | TRPM6 GABRG3 BEST3 HCN2 RYR1 RYR3 SLC9C1 CLCN1 NALCN OTOP1 GRIN3A ATP2A1 ATP2A2 KCNH5 | 4.73e-03 | 793 | 160 | 14 | GO:0015075 |
| GeneOntologyMolecularFunction | endonuclease activity | 4.81e-03 | 136 | 160 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 5.07e-03 | 86 | 160 | 4 | GO:0004197 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 5.17e-03 | 197 | 160 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 COL9A1 MXRA5 LAMA2 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-18 ERVK-5 ERVK-19 ERVK-25 ERVK-24 MUC4 | 5.39e-03 | 891 | 160 | 15 | GO:0005198 |
| GeneOntologyBiologicalProcess | blastocyst formation | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 CNOT1 PRAMEF6 | 8.39e-09 | 78 | 158 | 9 | GO:0001825 |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 STAT3 RIF1 PRAMEF14 PRAMEF6 | 1.06e-08 | 108 | 158 | 10 | GO:0035019 |
| GeneOntologyBiologicalProcess | DNA integration | 3.03e-08 | 13 | 158 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | PRAMEF7 PADI4 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 STAT3 RIF1 PRAMEF14 CNOT1 PRAMEF6 | 3.01e-07 | 237 | 158 | 12 | GO:0019827 |
| GeneOntologyBiologicalProcess | maintenance of cell number | PRAMEF7 PADI4 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 STAT3 RIF1 PRAMEF14 CNOT1 PRAMEF6 | 3.77e-07 | 242 | 158 | 12 | GO:0098727 |
| GeneOntologyBiologicalProcess | oocyte development | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 9.42e-07 | 99 | 158 | 8 | GO:0048599 |
| GeneOntologyBiologicalProcess | blastocyst development | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 NLRP9 PRAMEF14 CNOT1 PRAMEF6 | 1.24e-06 | 179 | 158 | 10 | GO:0001824 |
| GeneOntologyBiologicalProcess | oocyte differentiation | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 1.27e-06 | 103 | 158 | 8 | GO:0009994 |
| GeneOntologyBiologicalProcess | germ cell development | ADCY10 DNHD1 PRAMEF7 KLHL10 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 DNAH1 PRAMEF14 SPAG17 PRAMEF6 DNMT3L | 2.14e-05 | 482 | 158 | 14 | GO:0007281 |
| GeneOntologyBiologicalProcess | oogenesis | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 2.76e-05 | 156 | 158 | 8 | GO:0048477 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 3.25e-05 | 48 | 158 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | ADCY10 DNHD1 PRAMEF7 KLHL10 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 DNAH1 PRAMEF14 SPAG17 PRAMEF6 DNMT3L | 5.64e-05 | 527 | 158 | 14 | GO:0022412 |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | 1.53e-04 | 149 | 158 | 7 | GO:0062014 | |
| GeneOntologyBiologicalProcess | positive regulation of endoplasmic reticulum calcium ion concentration | 1.74e-04 | 3 | 158 | 2 | GO:0032470 | |
| GeneOntologyBiologicalProcess | cilium movement | 1.89e-04 | 261 | 158 | 9 | GO:0003341 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 2.79e-09 | 47 | 163 | 8 | GO:0031462 |
| GeneOntologyCellularComponent | motile cilium | ADCY10 DNHD1 PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 DNAH1 SLC9C1 DNAH12 PCDH11X SPAG17 DNAH6 DNAH9 CFAP99 PRAMEF6 | 2.81e-09 | 355 | 163 | 17 | GO:0031514 |
| GeneOntologyCellularComponent | inner dynein arm | 7.21e-07 | 10 | 163 | 4 | GO:0036156 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.27e-06 | 25 | 163 | 5 | GO:0005858 | |
| GeneOntologyCellularComponent | cilium | TNPO1 ADCY10 DNHD1 PRAMEF7 PRAMEF5 TBC1D30 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 DNAH1 CC2D2B SLC9C1 DNAH12 PCDH11X SPAG17 USH2A DNAH6 DNAH9 HYDIN CFAP99 PRAMEF6 | 1.96e-06 | 898 | 163 | 22 | GO:0005929 |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 WDTC1 | 4.45e-05 | 212 | 163 | 9 | GO:0031461 |
| GeneOntologyCellularComponent | dynein complex | 6.30e-05 | 54 | 163 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | acrosomal vesicle | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 SPAG17 PRAMEF6 | 2.19e-04 | 206 | 163 | 8 | GO:0001669 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 4.14e-04 | 45 | 163 | 4 | GO:0033017 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 6.31e-04 | 88 | 163 | 5 | GO:0016529 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 7.90e-04 | 378 | 163 | 10 | GO:0034702 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRG3 FOXRED1 BEST3 HCN2 RYR1 RYR3 CLCN1 NALCN GRIN3A ATP2A1 ATP2A2 KCNH5 | 8.45e-04 | 523 | 163 | 12 | GO:1902495 |
| GeneOntologyCellularComponent | axonemal central apparatus | 8.88e-04 | 6 | 163 | 2 | GO:1990716 | |
| GeneOntologyCellularComponent | axoneme | 1.22e-03 | 207 | 163 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | U2AF complex | 1.24e-03 | 7 | 163 | 2 | GO:0089701 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.26e-03 | 208 | 163 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | transporter complex | GABRG3 FOXRED1 BEST3 HCN2 RYR1 RYR3 CLCN1 NALCN GRIN3A ATP2A1 ATP2A2 KCNH5 | 1.30e-03 | 550 | 163 | 12 | GO:1990351 |
| GeneOntologyCellularComponent | apical plasma membrane | TRPM6 ADCY10 NOX4 CDHR5 LCT CBLIF BMPR2 PARD3 USH2A MUC4 SLC14A2 | 1.57e-03 | 487 | 163 | 11 | GO:0016324 |
| GeneOntologyCellularComponent | ubiquitin ligase complex | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 WDTC1 | 1.82e-03 | 352 | 163 | 9 | GO:0000151 |
| GeneOntologyCellularComponent | sarcoplasm | 2.01e-03 | 114 | 163 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 2.10e-03 | 9 | 163 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | junctional membrane complex | 2.10e-03 | 9 | 163 | 2 | GO:0030314 | |
| MousePheno | abnormal spermatogonia proliferation | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 1.11e-08 | 47 | 131 | 8 | MP:0002685 |
| MousePheno | abnormal jejunum morphology | 9.32e-08 | 41 | 131 | 7 | MP:0004002 | |
| MousePheno | abnormal duodenum morphology | 2.15e-06 | 64 | 131 | 7 | MP:0003271 | |
| MousePheno | increased male germ cell apoptosis | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 LIMK2 PRAMEF14 ZDHHC19 PRAMEF6 | 1.13e-05 | 189 | 131 | 10 | MP:0014052 |
| MousePheno | increased circulating amylase level | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 1.57e-05 | 119 | 131 | 8 | MP:0008806 |
| MousePheno | abnormal cecum morphology | 3.93e-05 | 99 | 131 | 7 | MP:0000494 | |
| MousePheno | increased kidney weight | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 6.52e-05 | 145 | 131 | 8 | MP:0003917 |
| MousePheno | abnormal ear physiology | PRAMEF7 COL9A1 PRAMEF5 NAGLU LAMA2 SCRN1 PRAMEF8 PRAMEF1 PRAMEF2 HCN2 PRAMEF13 CLCN1 PRAMEF14 OTOP1 PPIP5K2 USH2A PADI3 PRAMEF6 | 6.83e-05 | 684 | 131 | 18 | MP:0003878 |
| MousePheno | abnormal male germ cell apoptosis | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 LIMK2 PRAMEF14 ZDHHC19 PRAMEF6 | 7.53e-05 | 236 | 131 | 10 | MP:0008280 |
| MousePheno | abnormal auditory brainstem response | PRAMEF7 COL9A1 PRAMEF5 NAGLU LAMA2 SCRN1 PRAMEF8 PRAMEF1 PRAMEF2 HCN2 PRAMEF13 CLCN1 PRAMEF14 PPIP5K2 PADI3 PRAMEF6 | 9.58e-05 | 576 | 131 | 16 | MP:0004738 |
| MousePheno | azoospermia | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 HCN2 PRAMEF13 PRAMEF14 PRAMEF6 DNMT3L | 9.93e-05 | 244 | 131 | 10 | MP:0005159 |
| MousePheno | abnormal male germ cell physiology | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 LIMK2 PRAMEF14 ZDHHC19 PRAMEF6 | 9.93e-05 | 244 | 131 | 10 | MP:0020362 |
| MousePheno | abnormal hearing physiology | PRAMEF7 COL9A1 PRAMEF5 NAGLU LAMA2 SCRN1 PRAMEF8 PRAMEF1 PRAMEF2 HCN2 PRAMEF13 CLCN1 PRAMEF14 PPIP5K2 USH2A PADI3 PRAMEF6 | 1.05e-04 | 643 | 131 | 17 | MP:0001963 |
| MousePheno | abnormal spermatogenesis | ADCY10 DNHD1 PRAMEF7 ABCA1 KLHL10 PRAMEF5 ACOX1 LAMA2 PRAMEF8 PRAMEF1 PRAMEF2 HCN2 CREB3L4 PRAMEF13 LIMK2 PRAMEF14 ZDHHC19 SPAG17 TEX44 PRAMEF6 DNMT3L | 1.07e-04 | 910 | 131 | 21 | MP:0001156 |
| MousePheno | enlarged urinary bladder | 1.08e-04 | 116 | 131 | 7 | MP:0011874 | |
| MousePheno | abnormal circulating amylase level | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 1.09e-04 | 156 | 131 | 8 | MP:0008804 |
| MousePheno | abnormal hearing electrophysiology | PRAMEF7 COL9A1 PRAMEF5 NAGLU LAMA2 SCRN1 PRAMEF8 PRAMEF1 PRAMEF2 HCN2 PRAMEF13 CLCN1 PRAMEF14 PPIP5K2 PADI3 PRAMEF6 | 1.37e-04 | 594 | 131 | 16 | MP:0006335 |
| MousePheno | abnormal male germ cell morphology | ADCY10 DNHD1 PRAMEF7 ABCA1 PRAMEF5 ACOX1 LAMA2 PRAMEF8 PRAMEF1 PRAMEF2 HCN2 CREB3L4 PRAMEF13 LIMK2 PRAMEF14 ZDHHC19 SPAG17 TEX44 PRAMEF6 DNMT3L | 1.41e-04 | 859 | 131 | 20 | MP:0006362 |
| MousePheno | absent gametes | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 HCN2 PRAMEF13 PRAMEF14 PRAMEF6 DNMT3L | 1.47e-04 | 256 | 131 | 10 | MP:0001117 |
| MousePheno | enlarged spleen | PRAMEF7 PADI4 ABCA1 FOXRED1 PRAMEF5 IPO7 NLRP1 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 RYR1 RASGRP1 NLRP9 NALCN IGHM SEC24B NLRC5 WDFY3 PRAMEF6 | 1.48e-04 | 862 | 131 | 20 | MP:0000691 |
| MousePheno | abnormal kidney weight | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 SLC14A2 PRAMEF6 | 1.48e-04 | 208 | 131 | 9 | MP:0002707 |
| MousePheno | abnormal germ cell morphology | ADCY10 DNHD1 PRAMEF7 ABCA1 KLHL10 PRAMEF5 ACOX1 LAMA2 PRAMEF8 PRAMEF1 PRAMEF2 HCN2 CREB3L4 PRAMEF13 LIMK2 PRAMEF14 ZDHHC19 SPAG17 TEX44 PRAMEF6 DNMT3L | 1.84e-04 | 946 | 131 | 21 | MP:0002208 |
| MousePheno | abnormal foam cell morphology | ADCY10 DNHD1 PRAMEF7 ABCA1 KLHL10 PRAMEF5 ACOX1 LAMA2 PRAMEF8 PRAMEF1 PRAMEF2 HCN2 CREB3L4 PRAMEF13 LIMK2 PRAMEF14 ZDHHC19 SPAG17 TEX44 PRAMEF6 DNMT3L | 2.06e-04 | 954 | 131 | 21 | MP:0009840 |
| MousePheno | abnormal germ cell physiology | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 LIMK2 PRAMEF14 ZDHHC19 PRAMEF6 | 2.07e-04 | 267 | 131 | 10 | MP:0020363 |
| MousePheno | visceromegaly | PRAMEF7 PADI4 ABCA1 FOXRED1 PRAMEF5 IPO7 ACOX1 NLRP1 KBTBD2 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 RYR1 RASGRP1 NLRP9 NALCN IGHM SEC24B NLRC5 WDFY3 PRAMEF6 | 2.19e-04 | 1030 | 131 | 22 | MP:0013328 |
| MousePheno | increased B-1 B cell number | 2.23e-04 | 59 | 131 | 5 | MP:0004977 | |
| MousePheno | muscle spasm | 2.42e-04 | 60 | 131 | 5 | MP:0000743 | |
| MousePheno | infertility | ADCY10 DNHD1 PRAMEF7 ABCA1 KLHL10 PRAMEF5 ZRSR2 ACOX1 KBTBD2 PRAMEF8 PRAMEF1 PRAMEF2 HCN2 PRAMEF13 DNAH1 ZRSR2P1 SLC9C1 CLCN1 PRAMEF14 ZDHHC19 SPAG17 HYDIN PRAMEF6 DNMT3L | 2.53e-04 | 1188 | 131 | 24 | MP:0001924 |
| MousePheno | hearing/vestibular/ear phenotype | PRAMEF7 COL9A1 PRAMEF5 NAGLU LAMA2 SCRN1 IRF6 PRAMEF8 PRAMEF1 PRAMEF2 HCN2 PRAMEF13 CLCN1 PRAMEF14 SEC24B OTOP1 PPIP5K2 USH2A PADI3 PRAMEF6 | 2.82e-04 | 905 | 131 | 20 | MP:0005377 |
| MousePheno | abnormal testis weight | PRAMEF7 PRAMEF5 LAMA2 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 LIMK2 PRAMEF14 ZDHHC19 SLC14A2 PRAMEF6 | 3.07e-04 | 391 | 131 | 12 | MP:0004850 |
| MousePheno | abnormal B-1b B cell morphology | 3.08e-04 | 35 | 131 | 4 | MP:0008165 | |
| MousePheno | muscle twitch | 3.28e-04 | 64 | 131 | 5 | MP:0009046 | |
| MousePheno | male infertility | ADCY10 DNHD1 PRAMEF7 KLHL10 PRAMEF5 ACOX1 KBTBD2 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 DNAH1 SLC9C1 CLCN1 PRAMEF14 ZDHHC19 SPAG17 HYDIN PRAMEF6 DNMT3L | 4.86e-04 | 944 | 131 | 20 | MP:0001925 |
| MousePheno | decreased germ cell number | DNHD1 PRAMEF7 ABCA1 KLHL10 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 HCN2 CREB3L4 PRAMEF13 PRAMEF14 ZDHHC19 SPAG17 PRAMEF6 DNMT3L | 6.90e-04 | 687 | 131 | 16 | MP:0002209 |
| MousePheno | abnormal vitreous body morphology | PRAMEF7 PADI4 PRAMEF5 CYP7A1 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 INTS10 PRAMEF14 PRAMEF6 DNMT3L | 7.03e-04 | 429 | 131 | 12 | MP:0002699 |
| MousePheno | decreased testis weight | PRAMEF7 PRAMEF5 LAMA2 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 LIMK2 PRAMEF14 ZDHHC19 PRAMEF6 | 7.16e-04 | 370 | 131 | 11 | MP:0004852 |
| MousePheno | abnormal sperm number | DNHD1 PRAMEF7 ABCA1 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 HCN2 CREB3L4 PRAMEF13 PRAMEF14 ZDHHC19 SPAG17 PRAMEF6 DNMT3L | 7.41e-04 | 624 | 131 | 15 | MP:0002673 |
| MousePheno | abnormal lymph node size | PRAMEF7 PADI4 PRAMEF5 IPO7 NOX4 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 RASGRP1 IGHM SEC24B WDFY3 PRAMEF6 | 7.80e-04 | 561 | 131 | 14 | MP:0000701 |
| Domain | PRAME_family | 9.12e-11 | 19 | 151 | 7 | IPR026271 | |
| Domain | Dynein_heavy_dom-2 | 6.10e-08 | 14 | 151 | 5 | IPR013602 | |
| Domain | DHC_N2 | 6.10e-08 | 14 | 151 | 5 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 6.10e-08 | 14 | 151 | 5 | IPR011704 | |
| Domain | AAA_5 | 6.10e-08 | 14 | 151 | 5 | PF07728 | |
| Domain | DHC_fam | 9.09e-08 | 15 | 151 | 5 | IPR026983 | |
| Domain | Dynein_heavy | 9.09e-08 | 15 | 151 | 5 | PF03028 | |
| Domain | Dynein_heavy_dom | 9.09e-08 | 15 | 151 | 5 | IPR004273 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.86e-06 | 14 | 151 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.86e-06 | 14 | 151 | 4 | IPR024743 | |
| Domain | MT | 3.86e-06 | 14 | 151 | 4 | PF12777 | |
| Domain | AAA_8 | 3.86e-06 | 14 | 151 | 4 | PF12780 | |
| Domain | - | PRAMEF7 MXRA5 PRAMEF5 NLRP1 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 NLRP9 AMIGO3 NLRC5 PRAMEF6 | 1.20e-05 | 321 | 151 | 12 | 3.80.10.10 |
| Domain | L_dom-like | PRAMEF7 MXRA5 PRAMEF5 NLRP1 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 NLRP9 AMIGO3 NLRC5 PRAMEF6 | 1.49e-05 | 328 | 151 | 12 | IPR032675 |
| Domain | Ion_trans_dom | 3.92e-05 | 114 | 151 | 7 | IPR005821 | |
| Domain | Ion_trans | 3.92e-05 | 114 | 151 | 7 | PF00520 | |
| Domain | ConA-like_dom | 7.44e-05 | 219 | 151 | 9 | IPR013320 | |
| Domain | IMPORTIN_B_NT | 1.77e-04 | 14 | 151 | 3 | PS50166 | |
| Domain | Ryanodine_rcpt | 1.94e-04 | 3 | 151 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 1.94e-04 | 3 | 151 | 2 | IPR009460 | |
| Domain | RyR | 1.94e-04 | 3 | 151 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.94e-04 | 3 | 151 | 2 | PF06459 | |
| Domain | P-type_ATPase_IIA | 1.94e-04 | 3 | 151 | 2 | IPR005782 | |
| Domain | Ryan_recept | 1.94e-04 | 3 | 151 | 2 | IPR013333 | |
| Domain | IBN_N | 2.19e-04 | 15 | 151 | 3 | PF03810 | |
| Domain | IBN_N | 2.69e-04 | 16 | 151 | 3 | SM00913 | |
| Domain | Importin-beta_N | 3.24e-04 | 17 | 151 | 3 | IPR001494 | |
| Domain | LamGL | 3.85e-04 | 4 | 151 | 2 | SM00560 | |
| Domain | Fumarylacetoacetase_C-rel | 3.85e-04 | 4 | 151 | 2 | IPR011234 | |
| Domain | FAA_hydrolase | 3.85e-04 | 4 | 151 | 2 | PF01557 | |
| Domain | - | 3.85e-04 | 4 | 151 | 2 | 3.90.850.10 | |
| Domain | LamG-like | 3.85e-04 | 4 | 151 | 2 | IPR006558 | |
| Domain | ARM-type_fold | 4.44e-04 | 339 | 151 | 10 | IPR016024 | |
| Domain | U2AF_small | 6.39e-04 | 5 | 151 | 2 | IPR009145 | |
| Domain | PAD | 6.39e-04 | 5 | 151 | 2 | PF03068 | |
| Domain | PAD_N | 6.39e-04 | 5 | 151 | 2 | PF08526 | |
| Domain | PAD_M | 6.39e-04 | 5 | 151 | 2 | PF08527 | |
| Domain | PAD | 6.39e-04 | 5 | 151 | 2 | IPR004303 | |
| Domain | PAD_C | 6.39e-04 | 5 | 151 | 2 | IPR013530 | |
| Domain | Prot_Arg_deaminase_cen_dom | 6.39e-04 | 5 | 151 | 2 | IPR013733 | |
| Domain | PAD_N | 6.39e-04 | 5 | 151 | 2 | IPR013732 | |
| Domain | NACHT | 8.15e-04 | 23 | 151 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 8.15e-04 | 23 | 151 | 3 | IPR007111 | |
| Domain | RIH_assoc-dom | 9.53e-04 | 6 | 151 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 9.53e-04 | 6 | 151 | 2 | PF08709 | |
| Domain | RIH_assoc | 9.53e-04 | 6 | 151 | 2 | PF08454 | |
| Domain | Acid_Pase_AS | 9.53e-04 | 6 | 151 | 2 | IPR033379 | |
| Domain | RIH_dom | 9.53e-04 | 6 | 151 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 9.53e-04 | 6 | 151 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 9.53e-04 | 6 | 151 | 2 | IPR015925 | |
| Domain | - | 9.53e-04 | 6 | 151 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 9.53e-04 | 6 | 151 | 2 | PF01365 | |
| Domain | - | 1.04e-03 | 95 | 151 | 5 | 2.60.120.200 | |
| Domain | HIS_ACID_PHOSPHAT_2 | 1.33e-03 | 7 | 151 | 2 | PS00778 | |
| Domain | HIS_ACID_PHOSPHAT_1 | 1.33e-03 | 7 | 151 | 2 | PS00616 | |
| Domain | His_Pase_clade-2 | 1.76e-03 | 8 | 151 | 2 | IPR000560 | |
| Domain | His_Phos_2 | 1.76e-03 | 8 | 151 | 2 | PF00328 | |
| Domain | CNMP_BINDING_1 | 2.16e-03 | 32 | 151 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 2.16e-03 | 32 | 151 | 3 | PS00889 | |
| Domain | - | 2.22e-03 | 222 | 151 | 7 | 1.25.10.10 | |
| Domain | cNMP | 2.58e-03 | 34 | 151 | 3 | SM00100 | |
| Domain | cNMP_binding | 2.58e-03 | 34 | 151 | 3 | PF00027 | |
| Domain | MIR | 2.80e-03 | 10 | 151 | 2 | PF02815 | |
| Domain | MIR_motif | 2.80e-03 | 10 | 151 | 2 | IPR016093 | |
| Domain | MIR | 2.80e-03 | 10 | 151 | 2 | PS50919 | |
| Domain | MIR | 2.80e-03 | 10 | 151 | 2 | SM00472 | |
| Domain | Hydrolase_3 | 2.80e-03 | 10 | 151 | 2 | PF08282 | |
| Domain | cNMP-bd_dom | 2.80e-03 | 35 | 151 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 2.80e-03 | 35 | 151 | 3 | PS50042 | |
| Domain | - | ADCY10 DNHD1 ABCA1 ZGRF1 NLRP1 DNAH1 NLRP9 DNAH12 MDN1 SHPRH NLRC5 DNAH6 DNAH9 HYDIN | 2.95e-03 | 746 | 151 | 14 | 3.40.50.300 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 7.56e-06 | 183 | 103 | 9 | M997 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.22e-05 | 106 | 103 | 7 | M27200 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 4.15e-05 | 27 | 103 | 4 | M47755 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 4.37e-05 | 176 | 103 | 8 | MM15718 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 8.50e-05 | 99 | 103 | 6 | MM14910 | |
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 STAT3 PRAMEF14 PRAMEF6 | 1.95e-16 | 20 | 169 | 9 | 21425410 |
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 STAT3 PRAMEF14 PRAMEF6 | 3.55e-15 | 26 | 169 | 9 | 18500982 |
| Pubmed | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 NLRP9 PRAMEF14 PRAMEF6 | 7.77e-15 | 28 | 169 | 9 | 25089626 | |
| Pubmed | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 1.10e-14 | 18 | 169 | 8 | 23894331 | |
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 1.10e-14 | 18 | 169 | 8 | 12890732 |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 1.10e-14 | 18 | 169 | 8 | 29731491 |
| Pubmed | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 1.10e-14 | 18 | 169 | 8 | 14675769 | |
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 1.90e-14 | 19 | 169 | 8 | 28604677 |
| Pubmed | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 3.15e-14 | 20 | 169 | 8 | 26694250 | |
| Pubmed | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 3.15e-14 | 20 | 169 | 8 | 16580637 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-18 ERVK-5 ERVK-19 ERVK-25 ERVK-24 ERVK-11 | 3.95e-14 | 94 | 169 | 12 | 21542922 |
| Pubmed | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 7.94e-14 | 22 | 169 | 8 | 31729367 | |
| Pubmed | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 1.21e-13 | 23 | 169 | 8 | 19480014 | |
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 2.65e-13 | 25 | 169 | 8 | 12620990 |
| Pubmed | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 2.65e-13 | 25 | 169 | 8 | 37451217 | |
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 1.05e-12 | 17 | 169 | 7 | 23565261 | |
| Pubmed | 1.05e-12 | 17 | 169 | 7 | 37781892 | ||
| Pubmed | Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice. | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 1.41e-12 | 30 | 169 | 8 | 38786026 |
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 1.72e-12 | 18 | 169 | 7 | 39181896 | |
| Pubmed | 1.72e-12 | 18 | 169 | 7 | 18664271 | ||
| Pubmed | LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance. | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 2.51e-12 | 32 | 169 | 8 | 37889087 |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.55e-12 | 5 | 169 | 5 | 12629516 | |
| Pubmed | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 5.54e-12 | 35 | 169 | 8 | 19389355 | |
| Pubmed | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 5.87e-11 | 46 | 169 | 8 | 17287250 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 1.19e-10 | 50 | 169 | 8 | 31806660 |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 5.38e-10 | 4 | 169 | 4 | 10469592 | |
| Pubmed | 5.38e-10 | 4 | 169 | 4 | 7983737 | ||
| Pubmed | 1.97e-09 | 12 | 169 | 5 | 14557543 | ||
| Pubmed | 1.38e-08 | 58 | 169 | 7 | 31598710 | ||
| Pubmed | 1.56e-08 | 59 | 169 | 7 | 11279525 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | PRAMEF7 ABCA1 PRAMEF5 ZRSR2 ZGRF1 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 ZRSR2P1 MDN1 PRAMEF14 PRAMEF6 | 2.99e-08 | 363 | 169 | 13 | 14691545 |
| Pubmed | 3.71e-08 | 8 | 169 | 4 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 3.71e-08 | 8 | 169 | 4 | 19033399 | |
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 9971820 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 15972723 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 10516026 | ||
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 STAT3 RIF1 BMPR2 PRAMEF14 NOCT PRAMEF6 DNMT3L | 1.80e-07 | 424 | 169 | 13 | 21731673 |
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 9384575 | ||
| Pubmed | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 TRIP12 NLRP9 PER3 PRAMEF14 PRAMEF6 | 6.43e-07 | 326 | 169 | 11 | 17015433 | |
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | ERVK-6 PRAMEF7 PADI4 FMO1 HTR1D PRAMEF5 IRF6 LYSMD1 PRAMEF8 NUDT17 PRAMEF1 CSMD2 PRAMEF2 TRIM67 PER3 PRAMEF14 USH2A PADI3 PRAMEF6 | 7.33e-07 | 1031 | 169 | 19 | 16710414 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | TFIP11 F2 TRIP12 RYR3 DNAH12 MDN1 XIRP2 CAPN7 SHPRH USP7 MUC4 CNOT1 HYDIN | 1.08e-06 | 497 | 169 | 13 | 36774506 |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 1.12e-06 | 5 | 169 | 3 | 11401426 | |
| Pubmed | PRAMEF7 PADI4 ABCA1 PRAMEF5 ZRSR2 RFTN2 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 ZRSR2P1 NLRP9 PRAMEF14 USP7 PRAMEF6 | 1.18e-06 | 674 | 169 | 15 | 37196079 | |
| Pubmed | PRAMEF7 PRAMEF5 ZRSR2 TFIP11 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 ZRSR2P1 PRAMEF14 PRAMEF6 | 1.18e-06 | 347 | 169 | 11 | 16033648 | |
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 10444070 | ||
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 15063128 | ||
| Pubmed | 3.43e-06 | 129 | 169 | 7 | 23022380 | ||
| Pubmed | A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. | 9.27e-06 | 9 | 169 | 3 | 25640239 | |
| Pubmed | 1.32e-05 | 10 | 169 | 3 | 12970426 | ||
| Pubmed | 1.32e-05 | 10 | 169 | 3 | 18434328 | ||
| Pubmed | KCTD12 ABCA1 NIPSNAP1 PYY IRF6 RADIL TXNDC5 SHPRH PPIP5K2 MUC4 | 1.50e-05 | 371 | 169 | 10 | 15747579 | |
| Pubmed | ROBO4 MXRA5 IPO7 UBR4 CSMD2 RYR1 USP6 DNAH12 MDN1 TXNDC5 OTOP1 WDFY3 CNOT1 | 1.59e-05 | 638 | 169 | 13 | 31182584 | |
| Pubmed | 1.74e-05 | 32 | 169 | 4 | 23049088 | ||
| Pubmed | Sarcolemmal-restricted localization of functional ClC-1 channels in mouse skeletal muscle. | 2.35e-05 | 2 | 169 | 2 | 21078869 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 12556521 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 28114355 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 18981179 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 33691379 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 23402911 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 19644701 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 9489997 | ||
| Pubmed | CD22 associates with the human surface IgM-B-cell antigen receptor complex. | 2.35e-05 | 2 | 169 | 2 | 8475064 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 28742214 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 2.35e-05 | 2 | 169 | 2 | 12640042 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 33824475 | ||
| Pubmed | Sarco(endo)plasmic reticulum Ca2+ ATPases (SERCA1 and -2) in human extraocular muscles. | 2.35e-05 | 2 | 169 | 2 | 14638697 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 14592949 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 9799464 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 32500474 | ||
| Pubmed | PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion. | 2.35e-05 | 2 | 169 | 2 | 25833829 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 28126903 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 33754073 | ||
| Pubmed | CD22 is required for protection against West Nile virus Infection. | 2.35e-05 | 2 | 169 | 2 | 23302871 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 15718407 | ||
| Pubmed | Transportin-mediated nuclear import of heterogeneous nuclear RNP proteins. | 2.35e-05 | 2 | 169 | 2 | 9298975 | |
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 2.35e-05 | 2 | 169 | 2 | 17118445 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 11402072 | ||
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 2.35e-05 | 2 | 169 | 2 | 11500519 | |
| Pubmed | Differential expression of murine CGI-105 gene in 3T3-L1 cells by adrenocorticotropic hormones. | 2.35e-05 | 2 | 169 | 2 | 15774318 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 24901704 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 17517652 | ||
| Pubmed | Trip12 is an E3 ubiquitin ligase for USP7/HAUSP involved in the DNA damage response. | 2.35e-05 | 2 | 169 | 2 | 27800609 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 34502015 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 38339835 | ||
| Pubmed | Transportin-1 and Transportin-2: protein nuclear import and beyond. | 2.35e-05 | 2 | 169 | 2 | 24780099 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 12565913 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 9192302 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 2.35e-05 | 2 | 169 | 2 | 9460924 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 7556644 | ||
| Pubmed | Sarco(endo)plasmic reticulum Ca2+ ATPase isoforms and their role in muscle physiology and pathology. | 2.35e-05 | 2 | 169 | 2 | 10603953 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 17702752 | ||
| Pubmed | Characterizing SERCA Function in Murine Skeletal Muscles after 35-37 Days of Spaceflight. | 2.35e-05 | 2 | 169 | 2 | 34769190 | |
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 2.35e-05 | 2 | 169 | 2 | 15894801 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 25657002 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 18953100 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 16505165 | ||
| Pubmed | Zrsr2 and functional U12-dependent spliceosome are necessary for follicular development. | 2.35e-05 | 2 | 169 | 2 | 35198906 | |
| Pubmed | SERCA overexpression reduces hydroxyl radical injury in murine myocardium. | 2.35e-05 | 2 | 169 | 2 | 16798816 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 9817784 | ||
| Interaction | FBXO22 interactions | TFIP11 F2 TRIP12 RYR3 DNAH12 MDN1 TRIM67 XIRP2 CAPN7 SHPRH USP7 SNAI1 MUC4 CNOT1 HYDIN | 1.08e-05 | 540 | 148 | 15 | int:FBXO22 |
| Interaction | PTPRE interactions | 1.16e-05 | 69 | 148 | 6 | int:PTPRE | |
| Interaction | HSD17B7 interactions | 1.36e-05 | 42 | 148 | 5 | int:HSD17B7 | |
| Interaction | LATS1 interactions | SLAIN2 KCTD12 TFIP11 GPRC5A PRAMEF2 STK4 RIF1 DNAH12 MDN1 XIRP2 SEC24B PARD3 ATP2A1 | 2.27e-05 | 440 | 148 | 13 | int:LATS1 |
| Cytoband | 1p36.21 | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 8.87e-11 | 63 | 168 | 8 | 1p36.21 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | NBPF3 PRAMEF7 PADI4 HTR1D PRAMEF5 UBR4 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PER3 PRAMEF14 PADI3 PRAMEF6 WDTC1 | 3.79e-08 | 681 | 168 | 15 | chr1p36 |
| Cytoband | 3p21.31 | 5.16e-04 | 100 | 168 | 4 | 3p21.31 | |
| Cytoband | 19q13.1 | 1.10e-03 | 55 | 168 | 3 | 19q13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 1.14e-03 | 316 | 168 | 6 | chr3p21 | |
| Cytoband | 1p36.13 | 1.16e-03 | 56 | 168 | 3 | 1p36.13 | |
| GeneFamily | PRAME family | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 1.06e-12 | 24 | 111 | 8 | 686 |
| GeneFamily | Dyneins, axonemal | 3.01e-06 | 17 | 111 | 4 | 536 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.12e-04 | 3 | 111 | 2 | 287 | |
| GeneFamily | Armadillo repeat containing|Importins | 1.72e-04 | 18 | 111 | 3 | 596 | |
| GeneFamily | Peptidyl arginine deiminases | 3.69e-04 | 5 | 111 | 2 | 677 | |
| GeneFamily | NLR family | 4.69e-04 | 25 | 111 | 3 | 666 | |
| GeneFamily | ATPases Ca2+ transporting | 1.31e-03 | 9 | 111 | 2 | 1209 | |
| GeneFamily | Fibronectin type III domain containing | 3.08e-03 | 160 | 111 | 5 | 555 | |
| Coexpression | KINNEY_DNMT1_METHYLATION_TARGETS | 1.09e-09 | 34 | 156 | 7 | MM955 | |
| Coexpression | KOHOUTEK_CCNT2_TARGETS | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 TRIM67 PRAMEF14 PRAMEF6 | 1.34e-09 | 81 | 156 | 9 | MM938 |
| Coexpression | HUANG_GATA2_TARGETS_DN | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 TXNDC5 PRAMEF14 PRAMEF6 | 7.44e-09 | 98 | 156 | 9 | MM942 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED | 4.76e-08 | 57 | 156 | 7 | MM1262 | |
| Coexpression | MORI_SMALL_PRE_BII_LYMPHOCYTE_UP | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 1.31e-07 | 98 | 156 | 8 | MM592 |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS | PRAMEF7 ABCA1 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 TRIP12 PRAMEF14 PRAMEF6 | 1.34e-07 | 180 | 156 | 10 | MM612 |
| Coexpression | GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_DN | NUDT17 ITGAX FAM78A RASGRP1 OTOP1 PRSS45P KLHL14 USH2A DNMT3L | 2.01e-07 | 143 | 156 | 9 | M2956 |
| Coexpression | INGRAM_SHH_TARGETS_UP | PRAMEF7 FMO1 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 4.21e-07 | 156 | 156 | 9 | MM550 |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 MDN1 AMIGO3 PRAMEF14 PRAMEF6 | 1.38e-06 | 232 | 156 | 10 | MM1019 |
| Coexpression | DESCARTES_ORGANOGENESIS_SCHWANN_CELL_PRECURSOR | 2.03e-06 | 98 | 156 | 7 | MM3656 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | TRPM6 PRAMEF7 PRAMEF5 GDAP1 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRSS45P PRAMEF6 | 3.96e-06 | 261 | 156 | 10 | MM1277 |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | PRAMEF7 PRAMEF5 ZRSR2 NAGLU PRAMEF8 PRAMEF1 PRAMEF2 LCT PRAMEF13 RYR1 PRAMEF14 IGHM PRAMEF6 | 4.35e-06 | 463 | 156 | 13 | MM1011 |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3 | PRAMEF7 PADI4 PRAMEF5 LAMA2 PM20D1 LYSMD1 RFTN2 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 RYR1 PRAMEF14 HAPLN3 CTSO HYDIN PRAMEF6 | 6.83e-06 | 807 | 156 | 17 | MM855 |
| Coexpression | SANSOM_APC_TARGETS | PRAMEF7 PRAMEF5 TFIP11 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PRAMEF6 | 1.70e-05 | 245 | 156 | 9 | MM735 |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | PRAMEF7 PRAMEF5 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PAPPA ATP2A1 PRAMEF6 | 1.73e-05 | 309 | 156 | 10 | MM1244 |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K4ME3 | KCTD12 PRAMEF7 PRAMEF5 LYSMD1 RFTN2 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 CTSO PRAMEF6 CDHR4 | 4.51e-05 | 497 | 156 | 12 | MM863 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 5.26e-05 | 219 | 156 | 8 | M41199 | |
| Coexpression | GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 1.43e-04 | 189 | 156 | 7 | M5326 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL9A1 NRCAM CYP7A1 RYR3 DNAH1 PTPRD XIRP2 PCDH11X SPAG17 USH2A DNAH9 HYDIN | 2.57e-12 | 184 | 156 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL9A1 NRCAM CYP7A1 RYR3 DNAH1 PTPRD XIRP2 PCDH11X SPAG17 USH2A DNAH9 HYDIN | 2.57e-12 | 184 | 156 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL9A1 NRCAM CYP7A1 RYR3 DNAH1 PTPRD XIRP2 PCDH11X SPAG17 USH2A DNAH9 HYDIN | 2.57e-12 | 184 | 156 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-09 | 169 | 156 | 9 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.23e-08 | 196 | 156 | 9 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.23e-08 | 196 | 156 | 9 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 3.23e-08 | 196 | 156 | 9 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.57e-07 | 181 | 156 | 8 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.35e-07 | 194 | 156 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 4.52e-07 | 195 | 156 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.52e-07 | 195 | 156 | 8 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 4.52e-07 | 195 | 156 | 8 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.52e-07 | 195 | 156 | 8 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 4.52e-07 | 195 | 156 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 4.88e-07 | 197 | 156 | 8 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-06 | 154 | 156 | 7 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-06 | 154 | 156 | 7 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.45e-06 | 158 | 156 | 7 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.51e-06 | 159 | 156 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 159 | 156 | 7 | 00a157d033627d0e65c3fbd38d652c4cf56b47f6 | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.86e-06 | 164 | 156 | 7 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-06 | 167 | 156 | 7 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-06 | 178 | 156 | 7 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 3.44e-06 | 180 | 156 | 7 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.44e-06 | 180 | 156 | 7 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.70e-06 | 182 | 156 | 7 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.12e-06 | 185 | 156 | 7 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 4.42e-06 | 187 | 156 | 7 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-06 | 187 | 156 | 7 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 4.58e-06 | 188 | 156 | 7 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.74e-06 | 189 | 156 | 7 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.91e-06 | 190 | 156 | 7 | 169e600e95878000acf5d11f813f9028c7249646 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.91e-06 | 190 | 156 | 7 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.91e-06 | 190 | 156 | 7 | 17829f4de31b3d9e4d71ba4817d18842aa699773 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.91e-06 | 190 | 156 | 7 | 424550418c1bd4eb070cf3c41cf09fa9d89aef37 | |
| ToppCell | Ciliated_cells-A|World / lung cells shred on cell class, cell subclass, sample id | 4.91e-06 | 190 | 156 | 7 | cd87731aaa7d252424f79cfce9f7931457f17bdf | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.08e-06 | 191 | 156 | 7 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.08e-06 | 191 | 156 | 7 | 8a5a2188b13ef4bbfd626a42565566708a751c1b | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.08e-06 | 191 | 156 | 7 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.08e-06 | 191 | 156 | 7 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 5.08e-06 | 191 | 156 | 7 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.08e-06 | 191 | 156 | 7 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.08e-06 | 191 | 156 | 7 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.08e-06 | 191 | 156 | 7 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.08e-06 | 191 | 156 | 7 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.08e-06 | 191 | 156 | 7 | e314dd8f1a841cab847ae3703bedfe1bc623ac61 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.08e-06 | 191 | 156 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class (2021.01.30) | 5.08e-06 | 191 | 156 | 7 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.08e-06 | 191 | 156 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.08e-06 | 191 | 156 | 7 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class (2021.01.30) | 5.08e-06 | 191 | 156 | 7 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 5.08e-06 | 191 | 156 | 7 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.08e-06 | 191 | 156 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 5.26e-06 | 192 | 156 | 7 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 5.26e-06 | 192 | 156 | 7 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.63e-06 | 194 | 156 | 7 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-06 | 194 | 156 | 7 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.63e-06 | 194 | 156 | 7 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 5.63e-06 | 194 | 156 | 7 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.63e-06 | 194 | 156 | 7 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-06 | 194 | 156 | 7 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 5.63e-06 | 194 | 156 | 7 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|Epithelial_cells / Location, Cell class and cell subclass | 5.82e-06 | 195 | 156 | 7 | a3e2999fdd4c3575add6e28ecfd1d6606a61f992 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 6.22e-06 | 197 | 156 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.65e-06 | 199 | 156 | 7 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.65e-06 | 199 | 156 | 7 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.65e-06 | 199 | 156 | 7 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | Biopsy_Other_PF-Epithelial-Differentiating_Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.87e-06 | 200 | 156 | 7 | f7b4581d958afbd68f9045af619aaca0ab463439 | |
| ToppCell | Biopsy_IPF-Epithelial-Differentiating_Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 6.87e-06 | 200 | 156 | 7 | 8dfce65e417d6dcacb871d93d1539cdf807002fe | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.87e-06 | 200 | 156 | 7 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.87e-06 | 200 | 156 | 7 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Differentiating_Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.87e-06 | 200 | 156 | 7 | a552a99f5e4fa00dfb7775e5a3e1f62f1530d104 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.87e-06 | 200 | 156 | 7 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.87e-06 | 200 | 156 | 7 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Biopsy_IPF|World / Sample group, Lineage and Cell type | 6.87e-06 | 200 | 156 | 7 | 4de8c4789fb64250cb1dca94c108d39ab119bab4 | |
| ToppCell | Biopsy_IPF-Epithelial|Biopsy_IPF / Sample group, Lineage and Cell type | 6.87e-06 | 200 | 156 | 7 | 76f1ac00b34d07057d8da03d276438b719b46b1d | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.87e-06 | 200 | 156 | 7 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, condition lineage and cell class | 6.87e-06 | 200 | 156 | 7 | 221dd8d8851c47f2202ba848de3a041b17b1db3f | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.55e-06 | 136 | 156 | 6 | 47663c5d81c766a333207a44fc5b58b07309ee76 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.55e-06 | 136 | 156 | 6 | 6d2e5b871f4cf8d64e6fe0be666fb3490797c635 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.55e-06 | 136 | 156 | 6 | fd4269d194c7c11c6ab4383393a01efab05cbace | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.55e-06 | 136 | 156 | 6 | 3f6cec8d52c84191f7f6e2dd4dc47524dfd5b21b | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.55e-06 | 136 | 156 | 6 | 67d736096d6b6ddb4722809557f5e987063b8d23 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.19e-05 | 144 | 156 | 6 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.28e-05 | 146 | 156 | 6 | 7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.55e-05 | 151 | 156 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | Ciliated_cells-A-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.74e-05 | 154 | 156 | 6 | 3b938e23324f7edb56797b4a76fb96ff588142cf | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 154 | 156 | 6 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 154 | 156 | 6 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-05 | 155 | 156 | 6 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-05 | 155 | 156 | 6 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 160 | 156 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 160 | 156 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.23e-05 | 161 | 156 | 6 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.39e-05 | 163 | 156 | 6 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.83e-05 | 168 | 156 | 6 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.83e-05 | 168 | 156 | 6 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, Lineage and Cell Type | 2.83e-05 | 168 | 156 | 6 | 5b3fb1fc8fea810c6d4e6feb42c24fb57e8066de | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.93e-05 | 169 | 156 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.93e-05 | 169 | 156 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| Drug | nitrotyrosine | 4.62e-06 | 96 | 157 | 7 | CID000065124 | |
| Drug | mag-fura-2 | 5.33e-06 | 37 | 157 | 5 | CID000123839 | |
| Drug | AC1L380G | 7.78e-06 | 19 | 157 | 4 | CID000084698 | |
| Disease | intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (implicated_via_orthology) | 2.43e-05 | 2 | 146 | 2 | DOID:0081262 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 7.27e-05 | 3 | 146 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | Brody myopathy (implicated_via_orthology) | 7.27e-05 | 3 | 146 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 7.27e-05 | 3 | 146 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | NRCAM VPS39 UBR4 LAMA2 NUDT17 STAT3 RIF1 BMPR2 NLRP9 CLCN1 PTPRD PER3 NLRC5 SNAI1 DNAH9 PADI3 | 8.79e-05 | 1074 | 146 | 16 | C0006142 |
| Disease | Schizophrenia | DOCK4 KCTD12 ABCA1 VPS39 LAMA2 NLGN1 CSMD2 F2 CBLIF TXNDC5 ERVK-8 GRIN3A ATP2A2 DNMT3L | 1.30e-04 | 883 | 146 | 14 | C0036341 |
| Disease | DSGEGDFXAEGGGVR-to-ADpSGEGDFXAEGGGVR ratio | 1.45e-04 | 4 | 146 | 2 | EFO_0021395 | |
| Disease | ADSGEGDFXAEGGGVR-to-ADpSGEGDFXAEGGGVR ratio | 1.45e-04 | 4 | 146 | 2 | EFO_0021394 | |
| Disease | disease | 1.48e-04 | 21 | 146 | 3 | EFO_0000408 | |
| Disease | fibroblast growth factor 19 measurement | 2.41e-04 | 5 | 146 | 2 | EFO_0010782 | |
| Disease | primary pulmonary hypertension (is_implicated_in) | 3.60e-04 | 6 | 146 | 2 | DOID:14557 (is_implicated_in) | |
| Disease | fish oil supplement exposure measurement, high density lipoprotein cholesterol measurement | 5.02e-04 | 7 | 146 | 2 | EFO_0004612, EFO_0600007 | |
| Disease | phosphate measurement | 5.02e-04 | 7 | 146 | 2 | EFO_0010968 | |
| Disease | lactase-phlorizin hydrolase measurement | 6.68e-04 | 8 | 146 | 2 | EFO_0801753 | |
| Disease | osteoarthritis, spine, body mass index | 6.68e-04 | 8 | 146 | 2 | EFO_0004340, EFO_1000787 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 6.80e-04 | 80 | 146 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Kartagener Syndrome | 6.92e-04 | 35 | 146 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 6.92e-04 | 35 | 146 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 6.92e-04 | 35 | 146 | 3 | C4317124 | |
| Disease | heart disease (implicated_via_orthology) | 8.82e-04 | 38 | 146 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | thioredoxin domain-containing protein 12 measurement | 9.52e-04 | 39 | 146 | 3 | EFO_0008298 | |
| Disease | Congenital muscular dystrophy | 1.55e-03 | 12 | 146 | 2 | cv:C0699743 | |
| Disease | DNA methylation | 1.63e-03 | 656 | 146 | 10 | GO_0006306 | |
| Disease | disease progression measurement, Crohn's disease | 1.64e-03 | 47 | 146 | 3 | EFO_0000384, EFO_0008336 | |
| Disease | Primary Ciliary Dyskinesia | 1.64e-03 | 47 | 146 | 3 | C4551720 | |
| Disease | Rheumatoid Arthritis | 1.78e-03 | 174 | 146 | 5 | C0003873 | |
| Disease | Autistic Disorder | 1.96e-03 | 261 | 146 | 6 | C0004352 | |
| Disease | pathological myopia | 2.29e-03 | 111 | 146 | 4 | EFO_0004207 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 2.29e-03 | 111 | 146 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | cancer biomarker measurement | 2.45e-03 | 15 | 146 | 2 | EFO_0005127 | |
| Disease | Myopia | 2.45e-03 | 15 | 146 | 2 | C0027092 | |
| Disease | isoleucine measurement | 2.72e-03 | 56 | 146 | 3 | EFO_0009793 | |
| Disease | IGA glomerulonephritis | 3.00e-03 | 58 | 146 | 3 | EFO_0004194 | |
| Disease | systemic lupus erythematosus, COVID-19 | 3.00e-03 | 58 | 146 | 3 | MONDO_0007915, MONDO_0100096 | |
| Disease | heart disease (biomarker_via_orthology) | 3.15e-03 | 17 | 146 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 3.15e-03 | 17 | 146 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | non-alcoholic steatohepatitis (biomarker_via_orthology) | 3.15e-03 | 17 | 146 | 2 | DOID:0080547 (biomarker_via_orthology) | |
| Disease | cholesterol in medium HDL measurement | 3.15e-03 | 59 | 146 | 3 | EFO_0021903 | |
| Disease | Depressive disorder | 3.24e-03 | 289 | 146 | 6 | C0011581 | |
| Disease | free cholesterol in HDL measurement | 3.46e-03 | 61 | 146 | 3 | EFO_0022264 | |
| Disease | urate measurement, bone density | 3.78e-03 | 619 | 146 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | total lipids in HDL measurement | 3.79e-03 | 63 | 146 | 3 | EFO_0022307 | |
| Disease | Mammary Carcinoma, Human | 4.73e-03 | 525 | 146 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 4.73e-03 | 525 | 146 | 8 | C1257931 | |
| Disease | cardiac troponin T measurement | 4.77e-03 | 219 | 146 | 5 | EFO_0005043 | |
| Disease | Mammary Neoplasms | 4.84e-03 | 527 | 146 | 8 | C1458155 | |
| Disease | skin pigmentation measurement | 4.86e-03 | 137 | 146 | 4 | EFO_0007009 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QFVNLPWPDRLMFLI | 96 | Q8N1M1 | |
| MLGWIQPSRQPQLRA | 1 | P59051 | |
| LMPAVQNWLVEVPTV | 61 | O42043 | |
| CLMPAVQNWLVEVPT | 171 | O71037 | |
| CLMPAVQNWLVEVPT | 171 | Q902F8 | |
| LMPAVQNWLVEVPIV | 171 | Q9UKH3 | |
| MRLISIAPGPRWQVQ | 1 | Q7Z408 | |
| LEMFETVPVWRRQPV | 176 | Q9UJW3 | |
| QWVQLMVLSRPTPQL | 256 | O95267 | |
| VTNMQSLPPAIWNAE | 716 | Q0JRZ9 | |
| WTTAPVPQTIMDLFQ | 1436 | O95477 | |
| WVQPHTPQSLLATLM | 4351 | Q96M86 | |
| MNTPKEEFQDWPIVR | 1 | Q96PN6 | |
| NTSVPAMRIAWVSPQ | 301 | Q86WK7 | |
| RPNMTFWLLVRDTPG | 196 | Q9HBB8 | |
| MSLPTPIKQSWNFRL | 236 | Q6DHV5 | |
| TPMLVTDTEAFWQPQ | 671 | A6H8M9 | |
| LSENQSLLRMPPWVN | 916 | O14983 | |
| PLVRRPSLQMNTSIW | 516 | P54802 | |
| VSPEFWLLTKQRNPM | 261 | Q8NFJ5 | |
| MVFVRRPWPALTTVL | 1 | P10082 | |
| SPIWYSVQPISREQM | 736 | Q2TAL8 | |
| FLQRPVMWNSAAQTP | 396 | Q52LD8 | |
| RAMIDNWDVLFQVPP | 416 | Q6ZRI8 | |
| RPVLWVGVSMQFIPA | 616 | P20702 | |
| MFVNFPDQPVVWREI | 66 | Q9NVR2 | |
| SNPWLFEPLISRFME | 311 | Q6GTS8 | |
| PDLQPILFWMSNSIE | 501 | Q96JH8 | |
| DPLMRWQPEVQELIN | 151 | D6REC4 | |
| QDSVVFRVAPWIMTP | 286 | Q9UM07 | |
| ENSPLMSQPVWERYR | 4516 | Q99102 | |
| FVIPLDPRWNMQALD | 2591 | Q9NU22 | |
| RFVWIMLSQPLVGAQ | 201 | O15552 | |
| MASWAPQAQPLILQI | 326 | Q9UJ55 | |
| WMQQRAVLGPVPLTR | 196 | Q96S90 | |
| WLQDATVQYPIMLPR | 216 | Q96S86 | |
| IQPNPNEVSALMWLT | 201 | P0C025 | |
| PIIFWMDNSFQRLPQ | 176 | Q92823 | |
| FLRSMDPFPWQQKVR | 416 | P53671 | |
| NRTPVWFYMQIAPIR | 101 | Q8NCM2 | |
| FPNVAEEPIWRMIRQ | 1096 | P56645 | |
| TMSQVPLVLQAWNVP | 576 | Q9UIW2 | |
| QVSPQMWQLLPLVFE | 666 | O95373 | |
| PTMVVLFRWVPVTDA | 781 | Q9C000 | |
| PWFMRLNSTGEVPVL | 66 | Q8TB36 | |
| FILISQEPQPWIQIM | 606 | Q14D04 | |
| VLMWPRKINPIFDEN | 576 | Q6ZR08 | |
| QQNTWFPKTPMLFVR | 356 | Q8IY47 | |
| NIFPMVTLFHWDLPQ | 1011 | P09848 | |
| FEWSPAPMVQGVITR | 86 | H3BQJ8 | |
| VSRPIRWYPNISTVM | 2351 | P24043 | |
| AQKWPFQPSRDMRLV | 16 | Q96GK7 | |
| LPEVMLPVWFTNNLD | 126 | Q8N2Q7 | |
| STTMEIWIHPQPQRK | 1026 | Q9BZA7 | |
| LPMNVTVRDIPHWLN | 1516 | Q13219 | |
| LNTPVPMNLFATWEV | 16 | Q86VP3 | |
| TDTVVFRVAPWIMTP | 286 | Q9ULW8 | |
| CLMPAVQNWLVEVPT | 931 | P63135 | |
| IQVIRLWNNPIPCDM | 1826 | Q86WI3 | |
| MEEPRFQANFPQTWL | 271 | Q9NPH5 | |
| TIVLPPRNFWELLMN | 171 | Q9NQX7 | |
| ITTQFGVMPPELRWV | 341 | Q8TCU5 | |
| PWQRREERPLMVFNV | 811 | A8MVW0 | |
| MPLTPTVQGFQWTLR | 1 | Q9H094 | |
| EPWIIVVNLAMPFSI | 581 | Q7RTM1 | |
| AIRAYPTMPRTQWVL | 1416 | Q9P2D7 | |
| QRIQPQQVAVWPTMV | 461 | Q15067 | |
| QQVAVWPTMVDINSP | 466 | Q15067 | |
| SENQSLLRMPPWENI | 916 | P16615 | |
| PLMIDPQDQANRWIR | 3076 | Q9C0G6 | |
| SRIMFQLPADQVPDW | 3731 | Q4G0P3 | |
| SILQRQMENWAPSSP | 111 | P27352 | |
| TWRTIPTMFNPRSNF | 506 | Q6JEL2 | |
| FNSWIQLPPMQERRA | 401 | Q9P2G3 | |
| PLREFLTYPMQTEWQ | 1236 | Q8N1I0 | |
| VFVQWMQRGQPLSPE | 361 | P01871 | |
| WVRPEDLTNNPTMIY | 261 | Q9Y6W3 | |
| NMVGLIWIPDTIFRN | 121 | Q99928 | |
| LMPAVQNWLVEVPIV | 61 | P61566 | |
| CLMPAVQNWLVEVPI | 171 | P61570 | |
| CLMPAVQNWLVEVPT | 171 | Q69384 | |
| LMPAVQNWLVEVPTV | 61 | P61567 | |
| AQKWPFQPSRDMRLV | 16 | Q6P2I3 | |
| QAMWELPVQIPVLAS | 36 | Q10981 | |
| NMLRNSLPTPIVTWL | 241 | Q01740 | |
| SLMSPDQLRNKFPWI | 186 | Q96CU9 | |
| MIWERNKSVSPTVNP | 506 | Q13873 | |
| IPPLFWRQAKAQEEM | 171 | P28221 | |
| SQMEKIVRITWSNPP | 286 | P17174 | |
| VPFPPLIRAVTWMDN | 106 | P61565 | |
| LMPAVQNWLVEVPTV | 171 | P61565 | |
| LMPAVQNWLVEVPTV | 61 | Q9HDB8 | |
| PHMLTFLQQLRVDWP | 166 | Q5D0E6 | |
| NPQVSVPFELQWMLI | 226 | P20849 | |
| IPATFWSLFQMIRNP | 291 | P22680 | |
| CLMPAVQNWLVEVPT | 171 | Q902F9 | |
| LINCERWPLMVDPQL | 3456 | Q9NYC9 | |
| TLKTMVQAWPFTRLP | 51 | Q5VWM4 | |
| NLTQERNILPMTPVW | 526 | O95487 | |
| PVSWSRMPNHFLQVE | 1601 | P21817 | |
| FLVPMLQDFPRNCWV | 386 | Q9UL51 | |
| PDSLLWRMFTQQQPQ | 56 | Q96CX2 | |
| ISIQLDQWSPAFMVP | 136 | Q8TEY5 | |
| PPIRVMQWNILAQAL | 141 | Q9UK39 | |
| PIQLQWLLEGVPMRQ | 171 | P20273 | |
| TLTVMVQAWPFTCLP | 51 | Q5VWM6 | |
| QAMRTPIIWFHVVPA | 346 | Q8TEW0 | |
| MNTALIQWHPPVDTF | 836 | P23468 | |
| VPFWVRMSPEFVAVQ | 46 | Q14773 | |
| RILQTQESWQPMQPT | 441 | O14896 | |
| LLLEFSFWNEPQPRM | 166 | Q9BPW8 | |
| DWTFIQTPEIAPLMQ | 4621 | O75445 | |
| ITPWNFPSAMITRKV | 201 | P51649 | |
| PMQKSVSPLVWCRQV | 141 | Q9P270 | |
| IQWMSPDLFFRIFTP | 71 | Q4G0N8 | |
| WRMQLSIEVNPNRPL | 211 | Q5JUQ0 | |
| FRMPIINNLEWETVP | 261 | Q9HC36 | |
| TLTVMVQAWPFTCLP | 51 | Q5SWL7 | |
| PVDIILPQITSNMWA | 2301 | Q5UIP0 | |
| MRPLWVQYPQDVTTF | 726 | Q14697 | |
| IPVLRPYQREAVNWM | 301 | Q149N8 | |
| TLTVMVQAWPFTCLP | 51 | O95521 | |
| TLTVMVQAWPFTCLP | 51 | O60811 | |
| FQVWLTMGVENRNPP | 416 | Q8N122 | |
| QVPRTYAIMISRPAW | 61 | Q12765 | |
| EPTWDIMVRQSYPQR | 1251 | Q6Q759 | |
| PTIRWLLNGQPLSMV | 61 | Q8WZ75 | |
| RMLSPQPCLQQQIWT | 836 | Q7Z7M1 | |
| MSIPNVSLPLRFDWR | 101 | P43234 | |
| AQMQPSLPLQFLVWV | 151 | P35523 | |
| VFRPPNPWTMAIMNV | 1251 | A5YKK6 | |
| DWRQRQPMPIILSSL | 246 | Q7RTR0 | |
| MTAWINPPQISEIFQ | 76 | O14603 | |
| PLQVSMSLQNPAWDR | 96 | Q53QW1 | |
| LQPMWQLLPVEQDTS | 2031 | A4UGR9 | |
| AALTPRFQMFLWTPV | 131 | Q75MW2 | |
| LQPMNFSRALWVPVR | 51 | Q7RTY3 | |
| TLKTMVQAWPFTRLP | 51 | Q5VXH5 | |
| MRGQQPLTVFVELWL | 141 | Q5VXH4 | |
| LPMLIWDSVLAPQAQ | 56 | O95863 | |
| RVKRIATAPMWPNTF | 136 | Q8N5D0 | |
| RNNSVTLAWRMPPFT | 526 | Q6ZTA4 | |
| QPMITSIPLNLWGRD | 81 | P63127 | |
| QPMITSIPLNLWGRD | 81 | P63129 | |
| VRFWRMEFLQVPETP | 3241 | Q8IZQ1 | |
| LVEMQPQPSVQEWLV | 861 | Q9BX84 | |
| DVQTIQPVLWSRMPN | 1491 | Q15413 | |
| QPVLWSRMPNSFLKV | 1496 | Q15413 | |
| FPMELRQFLAPWIES | 26 | P40763 | |
| QPMITSIPLNLWGRD | 81 | P63121 | |
| QEVAPMLQQFIRPWC | 791 | O14787 | |
| QPMITSIPLNLWGRD | 81 | P63131 | |
| CLMPAVQNWLVEVPT | 931 | P10266 | |
| MRGQQPLTVFVELWL | 141 | Q5TYX0 | |
| QPMITSIPLNLWGRD | 81 | Q9Y6I0 | |
| QPMITSIPLNLWGRD | 81 | P63125 | |
| CLMPTVQNWLVEVPI | 931 | Q9UQG0 | |
| EPPLTNVFTMQWFLT | 421 | Q9Y2I9 | |
| QPMITSIPLNLWGRD | 81 | P10265 | |
| PMLQQFIRPWCTSLR | 796 | Q92973 | |
| ETQMPWSSPRVQRHF | 226 | Q8N393 | |
| PSNWPTNMVVHALLV | 1521 | Q86YA3 | |
| QPMITSIPLNLWGRD | 81 | P63123 | |
| LQRVVGPDWTSMPNL | 266 | Q8WVZ1 | |
| PWQVMLFRKSPQELL | 376 | P00734 | |
| ENWMLQTLNEEPVTP | 161 | Q8NBS9 | |
| RNTVIGTPFWMAPEV | 181 | Q13043 | |
| TTWQNPEPPVDFRVM | 156 | Q15695 | |
| PQSLQVFPQMIVKVW | 11 | Q5T6R2 | |
| VMRELAPQFHIPWSI | 346 | O43314 | |
| QPMITSIPLNLWGRD | 81 | P63122 | |
| LQDPLVIMTGNIPTW | 1516 | Q14669 | |
| WSDEMNPPQVIRTLL | 1301 | Q5T4S7 | |
| MPNITWSEVQVPLLL | 731 | Q15849 | |
| QTMGFPQDQIRLWPM | 611 | Q93009 | |
| TTWQNPEPPVDFRVM | 151 | Q15696 | |
| QPMITSIPLNLWGRD | 81 | P63119 | |
| MPFVRNIVTQWQPRN | 486 | Q9UBB9 | |
| IPMNIRGPVWSVLLN | 101 | P35125 | |
| TIMRELAPQFQIPWS | 356 | Q6PFW1 | |
| HFVWRLIPVPMATQI | 301 | Q96JC1 | |
| QPMITSIPLNLWGRD | 81 | P63120 | |
| WLPGVRFDIQMTQSP | 16 | A0A075B6H8 | |
| LIFLCWMPQNVPAES | 966 | Q8IZF0 | |
| VRAQILAEPEWVMQP | 421 | Q9NR99 |